SEC Form 4 · accession 0001209191-16-139146
DNIB UNWIND, INC. · BIND
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Tzianabos
Director
Period of report
Aug 26, 2016
Accepted (ET)
Aug 30, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001385228
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2016 | M | 15,000 | $0.44 | A | 15,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $0.44 | Aug 26, 2016 | M | 15,000 | D | — | Jun 20, 2026 | Common Stock | 15,000 | 0 | D |
Explanation of responses
- F1This option became fully vested and exercisable as a result of the sale of substantially all of the assets of DNIB Unwind, Inc. (f/k/a BIND Therapeutics, Inc.) (the "Company") on August 1, 2016 (the "Sale"). The Sale constituted a Change in Control (as defined in the Company's 2013 Incentive Award Plan).